Ansuvimab
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells[1].
Product Specifications
CAS Number
2375952-29-5
Product Name Alternative
Ansuvimab-zyk; mAb114
UNSPSC
12352203
Target
Filovirus
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ansuvimab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Ansuvimab]
Molecular Weight
(143.94 kDa)
References & Citations
[1]Lee A, et, al. Ansuvimab: First Approval. Drugs. 2021 Apr;81 (5) :595-598.|[2]Corti D, et, al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 2016 Mar 18;351 (6279) :1339-42.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Isoform
ZEBOV
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
